头孢吡肟
医学
哌拉西林/他唑巴坦
他唑巴坦
哌拉西林
泌尿系统
重症监护医学
内科学
抗生素
微生物学
细菌
抗生素耐药性
亚胺培南
遗传学
生物
铜绿假单胞菌
作者
Chi‐Kuei Hsu,Wen-Wen Tsai,Chih-Cheng Lai
出处
期刊:JAMA
[American Medical Association]
日期:2023-02-28
卷期号:329 (8): 684-684
标识
DOI:10.1001/jama.2022.22870
摘要
To the Editor A recent trial1 comparing the effect of cefepime/enmetazobactam vs piperacillin/tazobactam on complicated urinary tract infection or acute pyelonephritis found that patients receiving cefepime/enmetazobactam had a better primary outcome. We have some concerns about this study.
科研通智能强力驱动
Strongly Powered by AbleSci AI